Rani Therapeutics Holdings, Inc.
No trades
Funds holding the stock
Sorted by market value, the list below shows funds with Rani Therapeutics Holdings, Inc. Class A stocks. Equipped with price, change, and other helpful stats, they make investing in stocks more accessible and offer more opportunities at a lower risk.
Symbol | Market value | Weight | Issuer | Management style | Focus | Expense ratio | AUM | Price | Change % | Rel Volume | NAV total return 3Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
 IWCiShares Microcap ETF | 253.76 K USD | 0.02% | BlackRock, Inc. | Passive | Micro cap | 0.60% | 1.35 B USD | 168.40 USD | +2.32% | 0.58 | +45.35% |
| BTEEiShares NASDAQ US Biotechnology UCITS ETF | 88.02 K USD | 0.01% | BlackRock, Inc. | Passive | Health care | 0.35% | 54.9 M USD | 8.684 USD | +2.76% | 0.46 | +39.12% |
| BTECiShares NASDAQ US Biotechnology UCITS ETF | 88.02 K USD | 0.01% | BlackRock, Inc. | Passive | Health care | 0.35% | 921.01 M USD | 8.7175 USD | +2.59% | 1.26 | +39.13% |
 SBIOInvesco NASDAQ Biotech UCITS ETF | 41.26 K USD | 0.01% | Invesco Ltd. | Passive | Health care | 0.40% | 434.34 M USD | 62.41 USD | +2.60% | 3.24 | +39.12% |
| IBBQInvesco Nasdaq Biotechnology ETF | 6.82 K USD | 0.01% | Invesco Ltd. | Passive | Health care | 0.19% | 74.21 M USD | 29.72 USD | +1.99% | 0.22 | +40.43% |
 203780MIRAE ASSET TIGER NASDAQ BIO ETF | 6.74 K USD | 0.01% | Mirae Asset Global Investments Co., Ltd. | Passive | Health care | 0.30% | 71.78 M USD | 30,580 KRW | −1.12% | 0.54 | +57.18% |
 BIBProShares Ultra Nasdaq Biotechnology | 5.71 K USD | 0.01% | ProShare Advisors LLC | Passive | Health care | 0.95% | 89.17 M USD | 86.24 USD | +3.79% | 0.37 | +45.66% |
 00678Capital Nasdaq Biotechnology Index ETF | 125 USD | 0.00% | Qunyi Securities Investment Trust Co. Ltd. | Passive | Health care | 1.01% | 9.08 M USD | 35.57 TWD | −1.41% | 1.25 | +39.52% |